MENU
PCVX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Vaxcyte (PCVX) Earnings Date & Reports

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases... Show more

A.I. Advisor
published Earnings

PCVX is expected to report earnings to fall 16.67% to -129 cents per share on March 02

Vaxcyte PCVX Stock Earnings Reports
Q4'25
Est.
$-1.30
Q3'25
Missed
by $0.32
Q2'25
Missed
by $0.05
Q1'25
Est.
$-1.04
Q4'24
Beat
by $0.10
The last earnings report on November 04 showed earnings per share of -155 cents, missing the estimate of -124 cents. With 601.55K shares outstanding, the current market capitalization sits at 6.04B.
View a ticker or compare two or three
PCVX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PCVX showed earnings on November 04, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a company which engages in development of vaccines for infectious diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
825 Industrial Road
Phone
+1 650 837-0111
Employees
254
Web
https://www.vaxcyte.com